 | • レポートコード：MRC23Q36288 • 出版社/出版日：QYResearch / 2023年3月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、82ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥423,400 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥846,800 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の家禽/家畜抗感染症薬市場について調査・分析し、世界の家禽/家畜抗感染症薬市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（外用、内用）、用途別セグメント分析（牛、馬、豚、鶏、鴨、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Boehringer Ingelheim、Zoetis、Merck、Elanco、Bayer、Virbac、Ceva Sante Animale、Vetoquinol、Bimeda Animal Healthなどが含まれています。世界の家禽/家畜抗感染症薬市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、家禽/家畜抗感染症薬市場規模を推定する際に考慮しました。本レポートは、家禽/家畜抗感染症薬の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、家禽/家畜抗感染症薬に関するビジネス上の意思決定に役立てることを目的としています。 ・家禽/家畜抗感染症薬市場の概要 - 家禽/家畜抗感染症薬のタイプ別セグメント - 世界の家禽/家畜抗感染症薬市場規模：タイプ別分析（外用、内用） - 家禽/家畜抗感染症薬の用途別セグメント - 世界の家禽/家畜抗感染症薬市場規模：用途別分析（牛、馬、豚、鶏、鴨、その他） - 世界の家禽/家畜抗感染症薬市場規模予測（2018年-2029年） ・家禽/家畜抗感染症薬市場の成長トレンド - 家禽/家畜抗感染症薬の地域別市場規模（2018年-2029年） - 家禽/家畜抗感染症薬市場ダイナミクス - 家禽/家畜抗感染症薬の業界動向 - 家禽/家畜抗感染症薬市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：外用、内用 - 世界の家禽/家畜抗感染症薬のタイプ別市場規模（2018年-2023年） - 世界の家禽/家畜抗感染症薬のタイプ別市場規模（2024年-2029年） ・用途別セグメント：牛、馬、豚、鶏、鴨、その他 - 世界の家禽/家畜抗感染症薬の用途別市場規模（2018年-2023年） - 世界の家禽/家畜抗感染症薬の用途別市場規模（2024年-2029年） ・家禽/家畜抗感染症薬の地域別市場規模 - 北米の家禽/家畜抗感染症薬市場規模（2018年-2029年） - アメリカの家禽/家畜抗感染症薬市場規模（2018年-2029年） - ヨーロッパの家禽/家畜抗感染症薬市場規模（2018年-2029年） - アジア太平洋の家禽/家畜抗感染症薬市場規模（2018年-2029年） - 中国の家禽/家畜抗感染症薬市場規模（2018年-2029年） - 日本の家禽/家畜抗感染症薬市場規模（2018年-2029年） - 韓国の家禽/家畜抗感染症薬市場規模（2018年-2029年） - インドの家禽/家畜抗感染症薬市場規模（2018年-2029年） - オーストラリアの家禽/家畜抗感染症薬市場規模（2018年-2029年） - 中南米の家禽/家畜抗感染症薬市場規模（2018年-2029年） - 中東・アフリカの家禽/家畜抗感染症薬市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Boehringer Ingelheim、Zoetis、Merck、Elanco、Bayer、Virbac、Ceva Sante Animale、Vetoquinol、Bimeda Animal Health ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Poultry and Livestock Anti-Infective Drugs market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Poultry and Livestock Anti-Infective Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Poultry and Livestock Anti-Infective Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Poultry and Livestock Anti-Infective Drugs in Cattle is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Poultry and Livestock Anti-Infective Drugs include Boehringer Ingelheim, Zoetis, Merck, Elanco, Bayer, Virbac, Ceva Sante Animale, Vetoquinol and Bimeda Animal Health, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Poultry and Livestock Anti-Infective Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Poultry and Livestock Anti-Infective Drugs.
The Poultry and Livestock Anti-Infective Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Poultry and Livestock Anti-Infective Drugs market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Poultry and Livestock Anti-Infective Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Boehringer Ingelheim
Zoetis
Merck
Elanco
Bayer
Virbac
Ceva Sante Animale
Vetoquinol
Bimeda Animal Health
Segment by Type
External Use
Internal Use
Segment by Application
Cattle
Horse
Pig
Chicken
Duck
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Poultry and Livestock Anti-Infective Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Poultry and Livestock Anti-Infective Drugs Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 External Use
1.2.3 Internal Use
1.3 Market by Application
1.3.1 Global Poultry and Livestock Anti-Infective Drugs Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cattle
1.3.3 Horse
1.3.4 Pig
1.3.5 Chicken
1.3.6 Duck
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Poultry and Livestock Anti-Infective Drugs Market Perspective (2018-2029)
2.2 Poultry and Livestock Anti-Infective Drugs Growth Trends by Region
2.2.1 Global Poultry and Livestock Anti-Infective Drugs Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Poultry and Livestock Anti-Infective Drugs Historic Market Size by Region (2018-2023)
2.2.3 Poultry and Livestock Anti-Infective Drugs Forecasted Market Size by Region (2024-2029)
2.3 Poultry and Livestock Anti-Infective Drugs Market Dynamics
2.3.1 Poultry and Livestock Anti-Infective Drugs Industry Trends
2.3.2 Poultry and Livestock Anti-Infective Drugs Market Drivers
2.3.3 Poultry and Livestock Anti-Infective Drugs Market Challenges
2.3.4 Poultry and Livestock Anti-Infective Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Poultry and Livestock Anti-Infective Drugs Players by Revenue
3.1.1 Global Top Poultry and Livestock Anti-Infective Drugs Players by Revenue (2018-2023)
3.1.2 Global Poultry and Livestock Anti-Infective Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Poultry and Livestock Anti-Infective Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Poultry and Livestock Anti-Infective Drugs Revenue
3.4 Global Poultry and Livestock Anti-Infective Drugs Market Concentration Ratio
3.4.1 Global Poultry and Livestock Anti-Infective Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Poultry and Livestock Anti-Infective Drugs Revenue in 2022
3.5 Poultry and Livestock Anti-Infective Drugs Key Players Head office and Area Served
3.6 Key Players Poultry and Livestock Anti-Infective Drugs Product Solution and Service
3.7 Date of Enter into Poultry and Livestock Anti-Infective Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Poultry and Livestock Anti-Infective Drugs Breakdown Data by Type
4.1 Global Poultry and Livestock Anti-Infective Drugs Historic Market Size by Type (2018-2023)
4.2 Global Poultry and Livestock Anti-Infective Drugs Forecasted Market Size by Type (2024-2029)
5 Poultry and Livestock Anti-Infective Drugs Breakdown Data by Application
5.1 Global Poultry and Livestock Anti-Infective Drugs Historic Market Size by Application (2018-2023)
5.2 Global Poultry and Livestock Anti-Infective Drugs Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Poultry and Livestock Anti-Infective Drugs Market Size (2018-2029)
6.2 North America Poultry and Livestock Anti-Infective Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Poultry and Livestock Anti-Infective Drugs Market Size by Country (2018-2023)
6.4 North America Poultry and Livestock Anti-Infective Drugs Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Poultry and Livestock Anti-Infective Drugs Market Size (2018-2029)
7.2 Europe Poultry and Livestock Anti-Infective Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Poultry and Livestock Anti-Infective Drugs Market Size by Country (2018-2023)
7.4 Europe Poultry and Livestock Anti-Infective Drugs Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Poultry and Livestock Anti-Infective Drugs Market Size (2018-2029)
8.2 Asia-Pacific Poultry and Livestock Anti-Infective Drugs Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Poultry and Livestock Anti-Infective Drugs Market Size by Region (2018-2023)
8.4 Asia-Pacific Poultry and Livestock Anti-Infective Drugs Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Poultry and Livestock Anti-Infective Drugs Market Size (2018-2029)
9.2 Latin America Poultry and Livestock Anti-Infective Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Poultry and Livestock Anti-Infective Drugs Market Size by Country (2018-2023)
9.4 Latin America Poultry and Livestock Anti-Infective Drugs Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Poultry and Livestock Anti-Infective Drugs Market Size (2018-2029)
10.2 Middle East & Africa Poultry and Livestock Anti-Infective Drugs Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Poultry and Livestock Anti-Infective Drugs Market Size by Country (2018-2023)
10.4 Middle East & Africa Poultry and Livestock Anti-Infective Drugs Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Boehringer Ingelheim
11.1.1 Boehringer Ingelheim Company Detail
11.1.2 Boehringer Ingelheim Business Overview
11.1.3 Boehringer Ingelheim Poultry and Livestock Anti-Infective Drugs Introduction
11.1.4 Boehringer Ingelheim Revenue in Poultry and Livestock Anti-Infective Drugs Business (2018-2023)
11.1.5 Boehringer Ingelheim Recent Development
11.2 Zoetis
11.2.1 Zoetis Company Detail
11.2.2 Zoetis Business Overview
11.2.3 Zoetis Poultry and Livestock Anti-Infective Drugs Introduction
11.2.4 Zoetis Revenue in Poultry and Livestock Anti-Infective Drugs Business (2018-2023)
11.2.5 Zoetis Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Poultry and Livestock Anti-Infective Drugs Introduction
11.3.4 Merck Revenue in Poultry and Livestock Anti-Infective Drugs Business (2018-2023)
11.3.5 Merck Recent Development
11.4 Elanco
11.4.1 Elanco Company Detail
11.4.2 Elanco Business Overview
11.4.3 Elanco Poultry and Livestock Anti-Infective Drugs Introduction
11.4.4 Elanco Revenue in Poultry and Livestock Anti-Infective Drugs Business (2018-2023)
11.4.5 Elanco Recent Development
11.5 Bayer
11.5.1 Bayer Company Detail
11.5.2 Bayer Business Overview
11.5.3 Bayer Poultry and Livestock Anti-Infective Drugs Introduction
11.5.4 Bayer Revenue in Poultry and Livestock Anti-Infective Drugs Business (2018-2023)
11.5.5 Bayer Recent Development
11.6 Virbac
11.6.1 Virbac Company Detail
11.6.2 Virbac Business Overview
11.6.3 Virbac Poultry and Livestock Anti-Infective Drugs Introduction
11.6.4 Virbac Revenue in Poultry and Livestock Anti-Infective Drugs Business (2018-2023)
11.6.5 Virbac Recent Development
11.7 Ceva Sante Animale
11.7.1 Ceva Sante Animale Company Detail
11.7.2 Ceva Sante Animale Business Overview
11.7.3 Ceva Sante Animale Poultry and Livestock Anti-Infective Drugs Introduction
11.7.4 Ceva Sante Animale Revenue in Poultry and Livestock Anti-Infective Drugs Business (2018-2023)
11.7.5 Ceva Sante Animale Recent Development
11.8 Vetoquinol
11.8.1 Vetoquinol Company Detail
11.8.2 Vetoquinol Business Overview
11.8.3 Vetoquinol Poultry and Livestock Anti-Infective Drugs Introduction
11.8.4 Vetoquinol Revenue in Poultry and Livestock Anti-Infective Drugs Business (2018-2023)
11.8.5 Vetoquinol Recent Development
11.9 Bimeda Animal Health
11.9.1 Bimeda Animal Health Company Detail
11.9.2 Bimeda Animal Health Business Overview
11.9.3 Bimeda Animal Health Poultry and Livestock Anti-Infective Drugs Introduction
11.9.4 Bimeda Animal Health Revenue in Poultry and Livestock Anti-Infective Drugs Business (2018-2023)
11.9.5 Bimeda Animal Health Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
| 【家禽/家畜抗感染症薬について】 ※家禽及び家畜抗感染症薬は、動物の健康を保つために欠かせない重要な医薬品です。これらは、家禽（鶏、ダチョウ、アヒルなど）及び家畜（牛、豚、羊、馬など）に生じる様々な感染症を予防・治療するために使用されます。感染症は、動物の生産性を低下させるだけでなく、飼育環境や経済的側面にも大きな影響を与えるため、抗感染症薬の適切な使用が求められます。 抗感染症薬は、主に細菌、ウイルス、真菌などの病原体に対抗するために使用されます。それぞれの病原体に対する効果的な薬剤が開発されており、感染症の種類に応じて使い分ける必要があります。抗生物質やウイルスに対する抗ウイルス薬が一般的に用いられています。 抗生物質は、細菌感染症に対して用いられる薬剤であり、細菌の成長や繁殖を抑える効果があります。ペニシリン系、セフェム系、テトラサイクリン系、マクロライド系など、さまざまな種類があります。特定の細菌に対しては特定の薬剤が効果を示すため、病原体の特定が重要です。また、抗生物質の不適切な使用は耐性菌の形成を招く恐れがあり、これを防ぐためには適切な使用ガイドラインに従うことが必須です。 ウイルス感染に対しては、抗ウイルス薬が使用されます。ウイルスに対する治療法は限られているため、予防が特に重要です。予防接種やワクチン接種が一般的に行われ、これにより特定のウイルスによる感染症の発生を防ぐことが可能です。 真菌感染症に対しても、抗真菌薬が使用されますが、これらは家禽や家畜においては比較的少数派です。真菌感染は、主に免疫力が低下した動物に発生しやすく、適切な飼育管理と衛生状態が重要です。 これらの抗感染症薬は、用途によって異なる投与方法が選択されます。経口投与、注射、飲水への添加などが一般的です。飼育環境や動物の種類、目的によって適切な投与方法が選択されます。また、薬剤の効果を最大限に引き出すための投与時期や数量も重要です。 関連技術としては、遺伝子工学や生化学の進展が挙げられます。特定の病原体に対する有効成分の発見や改良、ワクチンの開発などがこれに含まれます。さらに、診断技術の進化により、病原体の早期発見が可能になり、迅速な対応が可能となります。これにより、抗感染症薬の使用がより効果的に行えるようになります。 飼育者としては、抗感染症薬の使用に関して適切な知識を持つことが重要です。使用目的や投与方法、効果、副作用、耐性菌の問題を理解し、適切に管理することで、家禽や家畜の健康を維持し、経済的な損失を防ぐことが求められます。また、環境への配慮も重要であり、薬剤の残留が環境に与える影響を考慮し、適切な廃棄方法や使用量の管理が必要です。 最後に、家禽及び家畜抗感染症薬の開発と使用は、動物の健康だけでなく、人間の健康や環境にも密接に関連しています。適切な薬剤の使用は、動物由来の感染症の蔓延を防ぎ、結果として食品安全にも寄与します。そのため、今後も抗感染症薬の研究や開発は重要な課題であり、技術革新や新しい治療法の確立が期待されます。動物医療の進歩とともに、抗感染症薬のより良い利用が求められる時代です。 |
